Upload
gregstone
View
41
Download
1
Embed Size (px)
DESCRIPTION
Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.
Citation preview
Microneedle Drug Delivery Patches,
Syringes & Systems
Devices, Players, Markets
and Forecasts
Report Prospectus
Greystone Research
associates
Greystone Research Associates is pleased to announce the publication of a new market study. Microneedle Drug Delivery Patches, Syringes & Systems: Devices, Players, Markets and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.
The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, healthcare segments and commercial opportunities for microneedle arrays and devices in the delivery of therapeutic drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Converging Technology that Addresses Unmet Medical Needs
Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.
Microneedle technology has the potential address the growing trend toward self-administration by allowing the precise placement of therapeutic agents at prescribed locations below the skin. But before microneedles find widespread use, developers must refine the techniques for large-scale manufacturing and for optimally inserting microneedles into the skin, and advance the design integration of microneedles into commercially viable drug delivery systems.
Managed Care Managers
Management Consultants
Financial Analysts
Product Developers
Component Suppliers
CMOs, CSOs
Pharma Product Managers
Device Suppliers
Biotech Managers
Drug Marketers
& Strategists Clinical
Managers
Drug Distributors
Pharma Regulators
Report Value Matrix
Mic
ro
ne
ed
le D
rug
De
liv
ery
Pa
tch
es
, S
yr
ing
es
& S
ys
tem
s
Executive Summary
Microneedle Medical Market Overview Drug Delivery & Self-Administration Chronic Conditions & Dosing Frequency Patient Safety and Compliance Microneedle Market Drivers The Trend to Minimally Invasive Medicine Shifting Patient Demographics Managed Care Initiatives Government Technology Transfer Programs
Microneedle Design & Technology Microneedle Form Factors Solid Microneedles Hollow Microneedles Coated Microneedles Dissolvable Microneedles Microneedle Arrays & Array Geometries Microneedle Manufacturing Material Selection Issues Fabrication Techniques Emerging Fabrication Methods
Medical Microneedles – Assessments & Commercialization Prospects
Solid Microneedle Arrays BA058 Patch ClickSoft DrugMAT Functional Microarray (FMA) MicroCor Micropatch Micropoint Patch sMTS ZP Patch Hollow Microneedle Arrays hMTS Transderm Micro-Trans Silicon Microneedles OnVax Phase Transition Microneedle Patch Dissolving Microneedle Chip Syringe Mounted Microneedles AdminPatch MicronJet NanoJect Soluvia Programmable Microneedle Patch
Near-Terms Markets - Sector Assessments and Forecasts
Dermatology/Cosmetic Surgery Genetic/DNA/Nucleotide Therapeutics Osteoporosis Reproductive Medicine Vaccines
Company Profiles
Table of Contents
Ordering Information
Orders may be placed via postal mail, e-mail or fax. Orders not accompanied by a purchase order must contain a
telephone number for verification, and clearly indicate the physical shipping address. Orders which are not prepaid must
indicate the billing address. There is no charge for handling and shipping for destination addresses within the continental US.
Payment
We accept the following forms of payment:
Company Check: Please make checks payable to ‘Greystone Associates’
Credit Cards: We accept MasterCard, Visa and American Express
Wire Transfers: See ’Wire Transfers’ below for more information
Orders Outside the U.S.
Orders must be prepaid via credit card, company check in US funds and drawn on a US bank, or wire transfer. There is a $50
per copy shipping and handling charge for international shipments.
Wire Transfers: TD Banknorth
300 Franklin Street
Manchester, NH 03103
(Call for Account Information)
Mailing Address: Greystone Research Associates
Client Services
P.O. Box 1362
Amherst, NH 03031
How To Order
98 Route 101A • P .O. Box 1362 • Amherst, NH 03031 • 603-595-4340 • (F) 603-218-7020 • [email protected]
Microneedle Drug Delivery Patches, Syringes & Systems: Devices, Players, Markets and Forecasts
Select Format Price (U.S. funds) Total
Electronic $2,850.00
Site License $4,850.00
Enterprise License $6,500.00
Total Payment (U.S. funds)
Method of Payment: ___ Company Check ___ ___ ___ ___ Wire Transfer (International) Card Number:___________________________ Name on Card ________________________________________
Expiration Date: ____________ Card CVV_______ Signature___________________________________
Billing Information Shipping Information
Click here if same as Billing Information
Name: Name:
Title: Title:
Company: Company:
Street Address: Street Address:
City,State/Province: City,State/Province:
Country/Postal Code: Country/Postal Code:
Phone: Phone:
Fax: Fax:
Email: Email:
98 Route 101A • P .O. Box 1362 • Amherst, NH 03031 • 603-595-4340 • (F) 603-218-7020 • [email protected]